Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Payables (2016 - 2026)

Sensus Healthcare has reported Payables over the past 11 years, most recently at $3.3 million for Q4 2025.

  • For Q4 2025, Payables fell 30.51% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, down 30.51%, while the annual FY2025 figure was $3.3 million, 30.51% down from the prior year.
  • Payables for Q4 2025 was $3.3 million at Sensus Healthcare, down from $5.6 million in the prior quarter.
  • Over five years, Payables peaked at $5.6 million in Q1 2025 and troughed at $450000.0 in Q1 2022.
  • A 5-year average of $3.5 million and a median of $3.5 million in 2024 define the central range for Payables.
  • On a YoY basis, Payables climbed as much as 360.08% in 2022 and fell as far as 84.09% in 2022.
  • Year by year, Payables stood at $1.2 million in 2021, then skyrocketed by 360.08% to $5.5 million in 2022, then plummeted by 49.41% to $2.8 million in 2023, then surged by 72.25% to $4.8 million in 2024, then tumbled by 30.51% to $3.3 million in 2025.
  • Business Quant data shows Payables for SRTS at $3.3 million in Q4 2025, $5.6 million in Q3 2025, and $5.4 million in Q2 2025.